Evidence map›Paper›PMID 32294942›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Identification and Testing of Antidermatophytic Oxaborole-6-Benzene Sulphonamide Derivative (OXBS) from

Seham Abdel-Shafi, Abdul-Raouf Al-Mohammadi, Taghreed N Almanaa, Ahmed H Moustafa, Tamer M M Saad, Abdel-Rahman Ghonemey, Immacolata Anacarso, Gamal Enan, Nashwa El-Gazzar

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Antimicrobial and cytotoxic activities of natural (Z)-13-docosenamide derived fromFrontiers in cellular and infection microbiology · 2025
    Article
  4. Antifungal and antibiofilm effects of probioticFrontiers in cellular and infection microbiology · 2024
    Article
  5. Article
  6. Article
  7. Silver-Protein Nanocomposites as Antimicrobial Agents.Nanomaterials (Basel, Switzerland) · 2021
    Article
  8. Assessment the using of silica nanoparticles (SiOSaudi journal of biological sciences · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Inhibition ofMolecules (Basel, Switzerland) · 2020
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Seham Abdel-ShafiDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, El-Sharqia 44519, Egypt.
Abdul-Raouf Al-MohammadiDepartment of Science, King Khalid Military Academy, Riyadh 11495, Saudi Arabia.
Taghreed N AlmanaaDepartment of Botany and Microbiology, College of Science, King Saud University, Riyadh 11495, Saudi Arabia.
Ahmed H MoustafaDepartment of Chemistry, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
Tamer M M SaadNuclear Materials Authority, Cairo 11381, Egypt.
Abdel-Rahman GhonemeyNuclear Materials Authority, Cairo 11381, Egypt.
Immacolata AnacarsoDepartment of Life Sciences, University of Modena and Reggio Emilia, Via Campi, 41121 Modena, Italy.
Gamal EnanDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, El-Sharqia 44519, Egypt.
Nashwa El-GazzarDepartment of Botany and Microbiology, Faculty of Science, Zagazig University, El-Sharqia 44519, Egypt.
Zagazig University · EGNuclear Materials Authority · EGKing Saud University · SAUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a need to continue research to find out other anti-dermatophytic agents to inhibit causal pathogenic skin diseases including many types of tinea. We undertook the production, purification, and identification of an anti-dermatophytic substance by

Indexed as

antifungal activitydermatophytesOXBSS. atrovirensstreptomycetes

Identifiers

PMID32294942
PMCPMC7235740
OpenAlexW3015432860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.